CytoVeris Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

CytoVeris General Information

Description

Developer of artificial intelligence-based optical imaging technologies designed to achieve tumor-free margins and improve patient outcomes. The company's technologies improve cancer resection for the real-time assessment of tissue, generate tissue molecular-specific information and produce an optical biomolecular fingerprint of cancer detection, enabling oncologists to reduce healthcare costs by minimizing the need for repeat surgeries.

Contact Information

Website
www.cytoveris.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 400 Farmington Avenue
  • Farmington, CT 06032
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Acquirer
OncoLux
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • 400 Farmington Avenue
  • Farmington, CT 06032
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoVeris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 01-Jun-2025 Completed Pre-Clinical Trials
7. Accelerator/Incubator 29-May-2024 Completed Pre-Clinical Trials
6. Early Stage VC 02-Nov-2021 Completed Pre-Clinical Trials
5. Grant 01-Nov-2021 Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 24-Apr-2020 Completed Product In Beta Test
3. Early Stage VC (Series A) 08-Oct-2018 Completed Product In Beta Test
2. Accelerator/Incubator Completed Product In Beta Test
1. Accelerator/Incubator Completed Product In Beta Test
To view CytoVeris’s complete valuation and funding history, request access »

CytoVeris Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view CytoVeris’s complete cap table history, request access »

CytoVeris Patents

  • 54

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

CytoVeris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260083330-A1 Method and system for enhanced fluorescence tissue and cancer margin imaging Pending 21-Sep-2023
US-20250082205-A1 Method and system for enhanced fluorescence tissue and cancer margin imaging Inactive 11-Sep-2023
US-20250076201-A1 Multispectral in-vivo imaging probe device for enhanced tissue visualization Pending 01-Sep-2023
US-20230366795-A1 Apparatus for supporting a tissue specimen Pending 11-May-2022
US-20230324300-A1 Autofluorescence-based biomolecular barcode approach for tissue classification Inactive 24-Mar-2022 G01N21/6456
To view CytoVeris’s complete patent history, request access »

CytoVeris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CytoVeris Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aimers Venture Partners Venture Capital Minority
Connecticut Innovations Venture Capital Minority
Cycle Venture Partners Venture Capital Minority
MedTech Innovator Accelerator/Incubator
National Cancer Institute Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

CytoVeris FAQs

  • When was CytoVeris founded?

    CytoVeris was founded in 2018.

  • Where is CytoVeris headquartered?

    CytoVeris is headquartered in Farmington, CT.

  • What is the size of CytoVeris?

    CytoVeris has 11 total employees.

  • What industry is CytoVeris in?

    CytoVeris’s primary industry is Diagnostic Equipment.

  • Is CytoVeris a private or public company?

    CytoVeris is a Private company.

  • What is CytoVeris’s current revenue?

    The current revenue for CytoVeris is .

  • How much funding has CytoVeris raised over time?

    CytoVeris has raised $10M.

  • Who are CytoVeris’s investors?

    Aimers Venture Partners, Connecticut Innovations, Cycle Venture Partners, MedTech Innovator, and National Cancer Institute are 5 of 6 investors who have invested in CytoVeris.

  • When was CytoVeris acquired?

    CytoVeris was acquired on 01-Jun-2025.

  • Who acquired CytoVeris?

    CytoVeris was acquired by OncoLux.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process